20 Future Romanian HealthTech and MedTech Leaders
- Nelson Advisors

- 2 hours ago
- 12 min read

The technological landscape of Romania has experienced a seismic shift between the fiscal years of 2024 and 2026, transitioning from a secondary outsourcing destination into a primary forge for high-valuation HealthTech and MedTech intellectual property. This metamorphosis is not merely anecdotal; it is substantiated by a radical escalation in capital inflow and a strategic pivot toward "Born Global" enterprises that prioritise international scalability from their inception.
The year 2025 stands as a historical inflection point for the region, where a single landmark financing event, the $165 Million Series C round for the robotics firm Dexory, nearly equaled the entire venture capital output of the Romanian ecosystem in 2024. This surge in liquidity, backed by global institutional heavyweights such as Atomico, Eurazeo and Lakestar, signals that the operational ceiling for Romanian-founded companies has been permanently elevated, transitioning the narrative from a regional hub to a consistent producer of global category leaders in medical and assistive technologies.
The maturation of the sector is further evidenced by the increasing density of DeepTech and AI-native startups. By early 2026, the Romania Tech Startup Association (ROTSA) and accelerators like Techcelerator had mapped over 100 artificial intelligence startups with Romanian roots, many of which are dedicated to solving high-complexity problems in oncology, radiotherapy, microbiome analysis and feline longevity. This report analyses 20 such leaders, representing a mix of high-growth scale-ups, innovative pre-seed ventures and visionary individuals who are redefining the intersection of healthcare and technology.
The Vanguard of Robotics and Assistive Technology
The intersection of hardware, sensor fusion, and healthcare has emerged as a dominant vertical within the Romanian innovation space. These companies leverage advanced engineering backgrounds, often rooted in automotive and aerospace sectors, to address fundamental human mobility and supply chain challenges.
1. Dexory: Autonomous Systems in the Healthcare Supply Chain
While Dexory is often categorized within the logistics and robotics sector, its implications for MedTech are profound. Founded by Andrei Danescu (CEO), Oana Andreea Jing, and Adrian Negoita, the company develops autonomous platforms that provide real-time digital twin technology for warehouse operations. The $165 Million Series C round in October 2025 provided the capital necessary to deploy these systems at a global scale.
In the context of healthcare, Dexory’s technology addresses the critical requirement for high-precision logistics in the pharmaceutical and medical device industries. The digital twin capabilities allow for the granular monitoring of sensitive medical inventories, ensuring that temperature-controlled environments are maintained and that the traceability of life-saving equipment meets stringent regulatory standards.
By automating data collection, Dexory eliminates the human error inherent in medical supply chains, a second-order effect that significantly enhances patient safety by ensuring that the right medical assets are available exactly when needed.
2. dotLumen: Advanced Mobility for the Visually Impaired
Founded by Cornel Amariei, dotLumen represents the pinnacle of Romanian assistive technology. Amariei, an inventor and researcher who previously led sensor innovation at Continental Automotive, has applied automotive-grade autonomous driving principles to human mobility. dotLumen produces smart glasses that utilize 3D scanners and vibrating sensors to assist the blind in navigating complex environments.
By 2025, dotLumen had secured approximately $30 Million in total funding, including an €11 Million grant from the European Innovation Council (EIC) Fund. The technological mechanism involves real-time spatial mapping, where the device "sees" the environment and provides haptic feedback to the user, effectively acting as a high-tech alternative to traditional guide dogs or walking canes. This innovation is a testament to the Romanian ecosystem’s ability to repurpose industrial engineering expertise for direct clinical and social impact.
AI-Driven Diagnostics and Radiography Leaders
Radiology and medical imaging have become the primary battlegrounds for AI adoption in Romania, driven by a deep talent pool in computer vision and machine learning.
3. Rayscape: The Maturation of Computer Vision in Radiology
Formerly operating as XVision, Rayscape has evolved into a comprehensive digital assistant for radiologists. Co-founded by Stefan Iarca, Cristian Avramescu, Bogdan Bercean, and Andrei Tenescu, the platform utilises deep learning to analyse chest X-rays and lung CT scans. The company’s trajectory from its 2018 founding in Timisoara to its 2024-2026 expansion exemplifies the successful scaling of a Romanian MedTech startup.
Rayscape’s impact is measured by clinical efficiency; in pilot projects at the County Emergency Clinical Hospital in Timisoara, the platform allowed radiologists to interpret 20% more images per day by prioritizing pathological cases. As of 2024, the company secured additional seed funding of €460,000, bringing its total financing to nearly €2 Million as it targets Western European and North American markets. The success of Rayscape is foundational to the Romanian MedTech narrative, proving that local algorithms can meet international clinical standards.
4. Synaptiq Technologies: Precision in Oncological Planning
Synaptiq Technologies addresses the "contouring" bottleneck in radiotherapy, where doctors must manually delineate tumors and organs at risk before treatment can begin. The team, led by Dragoș Dușe, Dragoș Grama and Marius Stănescu, brings together academic excellence from Heidelberg, Amsterdam and Bucharest. Dragoș Dușe, a physicist and machine learning researcher, previously designed algorithms at the German Cancer Research Institute.
Synaptiq’s AI reduces the time required for treatment planning from several hours to a matter of minutes, directly increasing the throughput of oncology departments. Nominated for "Best DeepTech Startup" and "Healtech & Longevity Innovator" at the 2026 Romania Startup Awards, the company represents a shift toward specialised AI that integrates deeply into the clinical workflow.
Leading HealthTech Entities | Primary Vertical | Key Founders / Leaders | Funding / Status (2025/26) |
Dexory | Robotics / Supply Chain | Andrei Danescu, Oana Jinga | $165M Series C |
dotLumen | Assistive Tech | Cornel Amariei | $30M Total |
Rayscape | Radiology AI | Stefan Iarca, Cristian Avramescu | €1.93M Total |
Synaptiq Technologies | Oncology AI | Dragoș Dușe, Marius Stănescu | Best DeepTech Nominee |
NostraBiome | Microbiome / Biotech | Calin Popescu, Valerio Lo Giudice | Best Fundraising Performer |
The Cat Health Company | Longevity Biotech | Alex Voda, Alex Bacita | €1.8M Total |
Digitail | Veterinary SaaS | Sebastian Gabor, Ruxandra Puiu | $37M Total |
Apollo AI Technologies | Pharma / NLP | Mihaela Onofrei, Vlad Trandafir | Female-Led Startup 2026 |
Hilio (Atlas) | Mental Health | Mihai Bran, Mihnea Bran | Telemedicine Leader |
Orbotix | MedTech / Robotics | Bogdan Ochiana, Gregory Letare | €7M Seed |
Microbiome, Longevity and Precision Medicine
The Romanian sector is increasingly exploring the frontiers of longevity and microbiome analysis, moving from reactive medicine to proactive, personalised health interventions.
5. NostraBiome: The Personalisation of Immune Response
NostraBiome is a DeepTech health company that utilises AI simulations to analyse the human microbiome, specifically targeting Inflammatory Bowel Disease (IBD) and oncology-related digestive issues. Founded by Calin Popescu, a serial entrepreneur with over 100 patents, the company was born from Popescu’s own decade-long struggle with IBD. By identifying unique microbial signatures, NostraBiome provides chronological recommendations to "hack" the inflammatory code of the individual patient.
The company’s leadership team includes CTO Valerio Lo Giudice and CMO Dr. Dragomir Radu Dumitru, a specialist at OncoHelp, the largest oncology center in Western Romania. NostraBiome has achieved remarkable results, with 90% of IBD patients in their studies reaching sustained remission. The startup’s success at the 2026 Romania Startup Awards, winning for revenue growth and fundraising, underlines the market’s appetite for precision medicine solutions that bridge the gap between AI and biological data.
6. The Cat Health Company (TCHC): Feline Longevity as a Human Proxy
Founded in 2024 by Oxford-trained scientist Alex Voda and former Charles River Labs senior scientist Alex Bacita, The Cat Health Company focuses on feline longevity. While the immediate product is longevity medicine for companion cats, the underlying mission is to accelerate human therapy discovery by using cats as a biological model for aging research.
TCHC secured €1.8 Million in seed funding, with participants including Early Game Ventures and Alex Zhavoronkov, the founder of the AI-driven pharma unicorn Insilico Medicine. The company’s approach involves in silico research to explore drug candidate libraries faster and more cost-effectively than traditional methods. By targeting the root causes of aging rather than just symptoms, TCHC is positioning Romania as a key node in the global longevity biotech network.
Veterinary and Pharmaceutical Innovations
The automation of clinical workflows and the democratisation of pharmaceutical data have emerged as critical sub-sectors, significantly reducing the administrative and cognitive load on healthcare providers.
7. Digitail: Revolutionising Veterinary Practice Management
Digitail, co-founded by Sebastian Gabor, Ruxandra Puiu, and Alexandru Tabolcea, is an all-in-one veterinary practice management platform (PIMS) that utilises AI to automate clinic workflows and pet owner communication. In November 2025, the company raised a $23 Million Series B round, bringing its total funding to $37 Million.
The platform’s global reach is extensive, supporting 10,000 veterinarians across 40 countries. Digitail’s success is a prime example of the "Born Global" Romanian strategy, where the founders moved rapidly to capture international market share, backed by elite investors like Google’s Gradient Ventures and Atomico. The second order insight here is the role of VetTech as a precursor to human HealthTech trends, particularly in remote monitoring and automated patient engagement.
8. Apollo AI Technologies: AI-Native Pharma Solutions
Founded in Iaşi in 2022, Apollo AI Technologies specializes in NLP and data mining for the healthcare sector. Led by Mihaela Onofrei and Vlad Trandafir, the company developed "Diabeta," a medical chatbot for diabetologists and "Pharmachat," which processes the specifications of all medicines approved in Romania.
Apollo’s most significant contribution is the creation of a map encompassing 1.7 Million drug-to-drug interactions, a tool that has been deployed in pharmacy chains to prevent adverse reactions. As the winner of the "Female-Led Startup of the Year" award in 2026, Apollo AI exemplifies the integration of computational linguistics into the pharmaceutical safety chain.
Mental Health and Telemedicine Pioneers
Mental health, once a neglected area in Eastern European healthcare, has seen a surge in digital innovation driven by the normalisation of remote care.
9. Hilio (formerly Atlas): The Maturation of Tele-Mental Health
Hilio, founded by psychiatrist Mihai Bran and Mihnea Bran, represents the evolution of the Romanian telemedicine market. Originally known as Atlas, the platform has transitioned into a comprehensive mental wellness ecosystem, providing access to therapy, coaching and corporate wellness programs. Dr. Mihai Bran’s work highlights the critical intersection of clinical expertise and entrepreneurial spirit, using the platform to improve the quality of life and accessibility of mental health services in Romania.
10. Medicai and Mircea Popa: Collaborative Medical Data
Mircea Popa, through his involvement with Medicai, has been a key figure in the digitization of medical records and image sharing in Romania. Medicai provides a platform that allows patients and doctors to securely share and collaborate on medical images, reducing the reliance on physical media like CDs.
Popa’s academic and professional activity through 2024 and 2025, including co-organising major IEEE conferences in intelligent engineering and medical cybernetics, demonstrates the deep scholarly roots of Romanian MedTech.

The "Innovator" Cohort: Emerging Leaders of 2026
The 2026 Romania Startup Awards nominated several early-stage companies that represent the next wave of HealthTech leadership. These entities focus on niche applications of DeepTech and specialised clinical needs.
11. Revelio Medical: Industrial MedTech Innovation
Nominated as a "Healtech & Longevity Innovator," Revelio Medical is part of a new class of startups focusing on the industrial application of medical technology. While specific technical details are often proprietary at this stage, their nomination alongside giants like Synaptiq indicates a high degree of market validation and investor interest.
12. Medical Pilot: Clinical Workflow Optimisation
Another ROTSA nominee, Medical Pilot, focuses on the "pilot" phase of healthcare delivery, optimising the initial interaction between patient data and clinical assessment. This startup addresses the critical need for more efficient triage and data-driven navigation within the Romanian healthcare system.
13. Nutribalance HealthTech: Personalising Nutritional Science
Nutribalance HealthTech represents the convergence of nutrition and digital health. By using data-driven insights to manage metabolic health and longevity, the company aligns with the broader global trend toward preventative healthcare and "nutrition as medicine."
14. Brain Symphony: Neuro-Focused Therapeutics
Nominated in the 2026 "Healtech & Longevity" category, Brain Symphony focuses on the complex field of neuroscience.Their work likely involves digital therapeutics or diagnostic tools designed to address cognitive decline and neurological performance, a sector of increasing importance as the European population ages.
15. Origin BCI: The DeepTech Frontier of Brain-Computer Interfaces
Origin BCI is perhaps the most ambitious of the 2026 nominees, categorised under "Best DeepTech Startup". By developing brain-computer interfaces, the company is pushing the boundaries of how humans interact with medical hardware, potentially offering new solutions for patients with severe motor or neurological impairments.
Financial Milestone | Startup | Amount / Stage | Date | Key Investors |
Largest Series C | Dexory | $165M | Oct 2025 | Atomico, Eurazeo, Lakestar |
Largest Debt Raise | Databricks (Zaharia) | $5B | Jan 2025 | Institutional Debt |
Top Series B | Digitail | $23M | Nov 2025 | Gradient Ventures, Partech |
EIC Grant | dotLumen | €11M | 2025 | EIC Fund |
Top Seed Round | Orbotix | €7M | 2025 | Bravo Victor VC |
Pre-Seed Biotech | TCHC | €500k | 2024 | Early Game Ventures |
Diaspora Leaders and Global Category Shapers
The influence of Romanian talent extends far beyond the nation’s borders, with founders in the United States and Western Europe leading some of the most innovative HealthTech companies in the world.
16. Emi Gal and Ezra: Early Cancer Detection
Emanuel "Emi" Gal, a serial entrepreneur from Bucharest, founded Ezra in 2018 with the mission of making full-body MRI cancer screening accessible. In May 2025, healthcare technology giants Function Health and Ezra announced their merger, with Function Health acquiring Ezra to integrate its MRI capabilities with lab-based health assessments.
Gal’s trajectory, from his education in Applied Mathematics at Spiru Haret University to leading a global AI healthcare merger, serves as an inspiration for the entire Romanian tech community.
17. Valar Labs and the 30 Under 30 Influence
The team at Valar Labs, including Romanian-linked founders featured in the Forbes 30 Under 30 Class of 2025 and 2026, represents the cutting edge of AI in oncology. Valar Labs uses AI to analyze tumor images to predict treatment response, helping patients find the most effective therapies. Their presence on international stages validates the high level of Romanian machine learning expertise on a global scale.
18. Etiq AI: Ensuring Ethical Algorithms in Healthcare
While often categorized under General AI, Etiq AI’s focus on ethical machine learning has significant implications for HealthTech, where algorithmic bias can have life-or-death consequences. Nominated for "Excellence in Artificial Intelligence" at the 2026 Romania Startup Awards, the company provides the oversight necessary for medical AI companies like Synaptiq or Rayscape to deploy their technologies safely and fairly.
19. Kinderpedia: Paediatric Health and Communication
Co-founded by Evelina Necula, Kinderpedia is an education and health management platform for children. While its primary market is EdTech, its role in pediatric health, tracking medical records, vaccinations and child development, makes it a critical leader in the "Healtech & Longevity" space. Their 2026 nomination for "Female-Led Startup of the Year" highlights the importance of integrated child-health management.
20. Parol: Automating the Clinical Record
Parol is an emerging leader focused on automating medical documentation. By using AI to capture and structure patient-doctor interactions, Parol reduces the administrative burden on Romanian healthcare providers, allowing for more patient-centric care. The company was recognised as a "Best Fundraising Performer" in 2026, signalling strong investor confidence in its ability to solve a universal pain point in healthcare systems.
Synthesis of Trends and Strategic Implications
The collective data from these 20 leaders suggests several critical trends shaping the Romanian HealthTech and MedTech landscape through 2026. First, there is a definitive shift from "SaaS-only" solutions to "DeepTech and Hardware-Enabled AI". Startups like dotLumen and Dexory prove that Romania can compete in capital-intensive hardware manufacturing when it is paired with proprietary AI software.
Second, the "Born Global" ethos has become the standard for Romanian founders. Companies like Digitail and The Cat Health Company target US and UK markets immediately, utilising Romania as a high-efficiency R&D hub while capturing higher-margin markets abroad.
This strategy is supported by local venture capital firms like GapMinder, which manages a €45 Million fund, and Early Game Ventures, which recently launched a €60 Million Fund II specifically to back early-stage CEE innovators.
Third, the emergence of longevity as a central theme, from feline studies (TCHC) to microbiome hacking (NostraBiome) and metabolic health (Nutribalance), indicates that Romania is moving beyond the management of acute illness toward the science of human healthspan extension.
Conclusion: The Path Toward the Next Unicorn
The Romanian HealthTech and MedTech sectors have moved beyond the experimental phase and are now in a period of aggressive scaling. The success of the 20 leaders profiled in this report, anchored by the record-breaking capital raises of 2025, suggests that the country’s first "HealthTech Unicorn" is imminent.
The convergence of academic excellence, a high-performing engineering workforce, and a maturing investor ecosystem has created a resilient infrastructure for innovation.
As these companies navigate regulatory submissions in 2026 and expand their clinical trials globally, they will not only bring prestige to the Romanian startup ecosystem but, more importantly, deliver transformative technologies to the global healthcare market.
The transition from "Hackerville" to a "Global HealthTech Hub" is well underway, fuelled by a generation of founders who are as scientifically rigorous as they are entrepreneurially ambitious.
Nelson Advisors > European MedTech and HealthTech Investment Banking
Nelson Advisors specialise in Mergers and Acquisitions, Partnerships and Investments for Digital Health, HealthTech, Health IT, Consumer HealthTech, Healthcare Cybersecurity, Healthcare AI companies. www.nelsonadvisors.co.uk
Nelson Advisors regularly publish Thought Leadership articles covering market insights, trends, analysis & predictions @ https://www.healthcare.digital
Nelson Advisors publish Europe’s leading HealthTech and MedTech M&A Newsletter every week, subscribe today! https://lnkd.in/e5hTp_xb
Nelson Advisors pride ourselves on our DNA as ‘Founders advising Founders.’ We partner with entrepreneurs, boards and investors to maximise shareholder value and investment returns. www.nelsonadvisors.co.uk
#NelsonAdvisors #HealthTech #DigitalHealth #HealthIT #Cybersecurity #HealthcareAI #ConsumerHealthTech #Mergers #Acquisitions #Partnerships #Growth #Strategy #NHS #UK #Europe #USA #VentureCapital #PrivateEquity #Founders #SeriesA #SeriesB #Founders #SellSide #TechAssets #Fundraising #BuildBuyPartner #GoToMarket #PharmaTech #BioTech #Genomics #MedTech
Nelson Advisors LLP
Hale House, 76-78 Portland Place, Marylebone, London, W1B 1NT
Meet Nelson Advisors @ 2026 Events
Digital Health Rewired > March 2026 > Birmingham, UK
NHS ConfedExpo > June 2026 > Manchester, UK
HLTH Europe > June 2026, Amsterdam, Netherlands
HIMSS AI in Healthcare > July 2026, New York, USA
Bits & Pretzels > September 2026, Munich, Germany
World Health Summit 2026 > October 2026, Berlin, Germany
HealthInvestor Healthcare Summit > October 2026, London, UK
HLTH USA 2026 > October 2026, USA
Barclays Health Elevate > October 2026, London, UK
Web Summit 2026 > November 2026, Lisbon, Portugal
MEDICA 2026 > November 2026, Düsseldorf, Germany
Venture Capital World Summit > Toronto, Canada





















































Comments